Clinic
Wyoming County
Wyoming County was paid $7.52M by Medicaid between Jan 2018 and Dec 2024, across 172 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.
33Billing provider infoWYOMING COUNTY
WARSAW, NY 14569
WARSAW, NY 14569
33aNPI1316924913assigned 12/27/2005
33bProvider typeEnd-Stage Renal Disease (ESRD) Treatment Clinic/Center
28Total paid$7.52M
24GClaims157,970
24DCodes billed172
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in New York
Rank by total paid#18 of 231
Median peer was paid$774K
This provider vs. median9.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 72 | $141.70 | |
| 2019 | 8,745 | $321K | |
| 2020 | 30,993 | $1.10M | |
| 2021 | 36,048 | $1.30M | |
| 2022 | 33,658 | $2.24M | |
| 2023 | 27,927 | $1.66M | |
| 2024incomplete | 20,527 | $908K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 7,963 | 7,653 | $1.50M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.7% | 3,741 | 3,603 | $655K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.1% | 4,887 | 4,428 | $612K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.7% | 2,529 | 2,473 | $506K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6.2% | 1,948 | 1,775 | $467K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.7% | 2,092 | 2,019 | $427K |
| 80053 | Comprehensive metabolic panel | 5.3% | 12,723 | 11,281 | $398K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 3.7% | 2,975 | 1,061 | $282K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.8% | 746 | 731 | $207K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.7% | 6,878 | 5,377 | $203K |
| 36415 | Collection of venous blood by venipuncture | 2.4% | 5,665 | 4,818 | $179K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.4% | 822 | 735 | $178K |
160 more codes
| 70450 | Computed tomography, head or brain; without contrast material | 1.9% | 473 | $142K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.6% | 1,280 | $121K |
| 81025 | 1.5% | 686 | $116K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.1% | 1,006 | $82K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.0% | 542 | $79K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,101 | $69K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,082 | $65K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 411 | $59K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 114 | $49K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 171 | $46K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 370 | $46K |
| 87428 | <1% | 622 | $42K | |
| 87631 | <1% | 317 | $42K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,337 | $41K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 134 | $36K |
| G0378 | Hospital observation service, per hour | <1% | 212 | $35K |
| 86850 | <1% | 445 | $33K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,063 | $32K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,155 | $30K |
| 80061 | Lipid panel | <1% | 4,204 | $30K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,786 | $29K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,640 | $28K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,121 | $28K |
| 80306 | <1% | 1,188 | $27K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,143 | $25K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 136 | $24K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 227 | $24K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,650 | $24K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,018 | $22K |
| 82607 | <1% | 1,740 | $21K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 152 | $20K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,504 | $19K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,680 | $17K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 434 | $16K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,428 | $16K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 171 | $15K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 127 | $15K |
| 84466 | <1% | 1,089 | $13K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 183 | $12K |
| 82728 | <1% | 854 | $11K | |
| 87070 | <1% | 1,249 | $10K | |
| 90686 | <1% | 460 | $9K | |
| 12001 | <1% | 26 | $9K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 227 | $9K |
| 84439 | <1% | 874 | $8K | |
| 86900 | <1% | 540 | $8K | |
| 82746 | <1% | 650 | $8K | |
| 85027 | <1% | 2,284 | $8K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 187 | $7K |
| 73564 | <1% | 390 | $7K | |
| 83540 | <1% | 1,269 | $7K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 119 | $7K |
| 87077 | <1% | 1,123 | $7K | |
| 83655 | <1% | 508 | $7K | |
| 73630 | <1% | 860 | $6K | |
| 87660 | <1% | 420 | $6K | |
| 97802 | <1% | 226 | $6K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 418 | $6K |
| 73610 | <1% | 459 | $6K | |
| 86901 | <1% | 523 | $5K | |
| 99441 | <1% | 83 | $5K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,940 | $5K |
| 99156 | <1% | 85 | $5K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,450 | $5K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 13 | $5K |
| 87480 | <1% | 343 | $5K | |
| 87510 | <1% | 323 | $5K | |
| 97162 | <1% | 39 | $5K | |
| 73030 | <1% | 478 | $4K | |
| 72110 | <1% | 253 | $4K | |
| 83690 | <1% | 1,693 | $4K | |
| 81001 | <1% | 2,564 | $4K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 13 | $4K |
| 93017 | <1% | 12 | $4K | |
| 86803 | <1% | 390 | $4K | |
| 84484 | <1% | 1,620 | $4K | |
| 76830 | Ultrasound, transvaginal | <1% | 56 | $3K |
| 83735 | <1% | 1,117 | $3K | |
| 87186 | <1% | 809 | $3K | |
| 85610 | <1% | 1,557 | $3K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 692 | $3K |
| 84703 | <1% | 1,441 | $3K | |
| 90670 | <1% | 163 | $3K | |
| 85730 | <1% | 963 | $3K | |
| 81002 | <1% | 1,641 | $2K | |
| 81003 | <1% | 2,207 | $2K | |
| 0012A | <1% | 70 | $2K | |
| 76801 | <1% | 43 | $2K | |
| 87430 | <1% | 792 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 594 | $2K |
| 80076 | <1% | 194 | $2K | |
| 86703 | <1% | 145 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 88 | $2K |
| 90685 | <1% | 102 | $2K | |
| 84702 | <1% | 202 | $2K | |
| 85652 | <1% | 902 | $2K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 187 | $2K |
| 82150 | <1% | 553 | $2K | |
| 85379 | <1% | 329 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 412 | $2K |
| 0011A | <1% | 121 | $2K | |
| 86592 | <1% | 377 | $1K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 80 | $1K |
| 73110 | <1% | 231 | $1K | |
| 87807 | <1% | 279 | $1K | |
| 86140 | <1% | 362 | $1K | |
| 84403 | <1% | 42 | $1K | |
| 90715 | <1% | 51 | $1K | |
| 87536 | <1% | 13 | $1K | |
| 90647 | <1% | 50 | $925.02 | |
| 83880 | <1% | 31 | $887.56 | |
| 87081 | <1% | 188 | $776.60 | |
| 84402 | <1% | 28 | $737.72 | |
| 90723 | <1% | 40 | $714.00 | |
| 82043 | <1% | 123 | $680.15 | |
| 90680 | <1% | 38 | $678.30 | |
| 0031A | <1% | 17 | $640.00 | |
| 87340 | <1% | 61 | $634.76 | |
| 83605 | <1% | 486 | $588.26 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 52 | $535.52 |
| 86762 | <1% | 32 | $492.88 | |
| 87254 | <1% | 51 | $483.02 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 12 | $453.96 |
| 86759 | <1% | 43 | $448.01 | |
| 73130 | <1% | 73 | $415.30 | |
| 96127 | <1% | 161 | $375.78 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 265 | $332.98 |
| 84550 | <1% | 75 | $326.68 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 14 | $295.58 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 38 | $290.56 |
| 87040 | <1% | 162 | $260.13 | |
| 73562 | <1% | 15 | $243.06 | |
| 90633 | <1% | 12 | $214.20 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,999 | $195.85 |
| 86038 | <1% | 27 | $158.69 | |
| J2704 | Injection, propofol, 10 mg | <1% | 476 | $146.21 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,727 | $132.63 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 14 | $122.52 |
| 87205 | <1% | 53 | $102.83 | |
| 82800 | <1% | 28 | $101.42 | |
| 74018 | <1% | 38 | $98.15 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 696 | $84.65 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 50 | $76.68 |
| 84436 | <1% | 12 | $69.57 | |
| 73080 | <1% | 14 | $63.01 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 320 | $20.28 |
| 83550 | <1% | 28 | $13.82 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 91 | $1.84 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 56 | $0.50 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 46 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 16 | $0.00 |
| 90461 | 0% | 96 | $0.00 | |
| 1159F | 0% | 27 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 13 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 26 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 18 | $0.00 |
| 3008F | 0% | 87 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 15 | $0.00 |
| 3044F | 0% | 15 | $0.00 | |
| 3079F | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCORCIMIGLIA, MICHAEL (COO)
| Provider | Location | Paid |
|---|---|---|
| Wyoming County | Warsaw, NY | $315K |
| Wyoming County | Warsaw, NY | $32K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.